FUROGAL T 100tab - infections in turkey poults, turkeys, chicks and turkey poults, and pheasants

FUROGAL T, tablets for poultry (chickens, turkeys, chicken and turkey chicks, pheasants).

STATEMENT OF ACTIVE SUBSTANCES AND OTHER INGREDIENTS:
1 tablet contains:
Active substances:
Tylosin tartrate ...... 12 mg
Sulfadimethoxine ...... 16 mg

INDICATIONS:
FUROGAL T is recommended for the prevention (in flocks where the diagnosis has been confirmed) and treatment of primary and secondary bacterial infections—respiratory and digestive—caused by pathogens susceptible to tylosin and sulfadimethoxine in chickens, turkeys, chicken and turkey chicks, and pheasants, as well as for the treatment of coccidiosis in the target species.

CONTRAINDICATIONS:
Do not administer to birds producing eggs for human consumption. Do not administer to birds with hypersensitivity to the active substances or to any of the excipients.

ADVERSE REACTIONS:
In general, sulfonamides have low toxicity.
If serious reactions or other effects not mentioned in the product leaflet are observed, please inform the veterinarian.

TARGET SPECIES:
Poultry: chickens, turkeys, chicken chicks, turkey chicks, and pheasants.

DOSAGE FOR EACH SPECIES, ROUTES AND METHODS OF ADMINISTRATION:
The product is administered orally, either individually or by mixing crushed tablets into the concentrated feed:
- chicken and turkey chicks: 1 tablet/chick/day, for 3–5 days.
- chickens, turkeys: 2 tablets/bird/day, for 3–5 days. - pheasants: 1 tablet/pheasant/day, for 3 days.

RECOMMENDATIONS FOR CORRECT ADMINISTRATION:
Strictly adhere to the recommended dosages.

WITHDRAWAL PERIOD(S):
Meat and offal - 5 days.
Do not administer to birds producing eggs for human consumption.

SPECIAL STORAGE PRECAUTIONS:
Keep out of the sight and reach of children.
Store below 25°C.
Protect from frost.
Store in the original package.
Keep the container tightly closed.
Protect from direct light.
Store in a dry place.
Do not use after the expiry date stated on the label.
Store in a dry place. Shelf life of the veterinary medicinal product as packaged for sale: 2 years.

SPECIAL WARNINGS:
Special warnings (for each target species):
None.
Special precautions for use in animals:
Use of the product should be based on susceptibility testing of bacteria isolated from the animals. If this is not possible, treatment should be based on epidemiological information (regional or farm-level) regarding the susceptibility of the target bacteria. Use of the product deviating from the instructions provided in the SPC may increase the prevalence of bacteria resistant to the active substances and may reduce the effectiveness of treatment with other antimicrobials, due to the potential for cross-resistance. Official, national, and regional antimicrobial policies must be taken into account when using the product. Special precautions to be taken by the person administering the veterinary medicinal product to animals:
Persons with known hypersensitivity to the active substances should avoid contact with the veterinary medicinal product. In case of accidental ingestion, seek medical advice and show the package leaflet or the label to the physician. Wash hands after use.
Use during the laying period:
Do not administer to birds producing eggs for human consumption.
Interactions with other medicinal products or other forms of interaction:
Sulfonamides are antagonistic to substances that release para-aminobenzoic acid upon hydrolysis (aniline derivatives, anesthesin, procaine), as well as to folic acid, vitamin PP, brewer's yeast (bacterial growth factors), methionine, peptone, and boric acid.
Overdose (symptoms, emergency procedures, antidotes), if applicable:
In general, sulfonamides have low toxicity. Minimum lethal doses reach 0.2–0.4% of body weight. However, cases of intoxication may occur when therapeutic doses are exceeded and treatment is prolonged.
Incompatibilities:
Sulfonamides are antagonistic to substances that release para-aminobenzoic acid upon hydrolysis (aniline derivatives, anesthesin, procaine), as well as to folic acid, vitamin PP, brewer's yeast (bacterial growth factors), methionine, peptone, and boric acid. In the absence of compatibility studies, this veterinary medicinal product must not be mixed with other veterinary medicinal products. SPECIAL PRECAUTIONS FOR THE DISPOSAL OF UNUSED PRODUCT OR WASTE MATERIALS, IF ANY:
Medicines should not be disposed of via wastewater or household waste. Any unused veterinary medicinal product or waste materials derived from such products must be disposed of in accordance with local requirements. Treated animals must be kept in housing throughout the treatment period, and their manure must be collected and must NOT be used to fertilize the soil.

SIZE:
Bottle containing 100 tablets.